
|Articles|July 1, 2015
Addressing Pharma Industry Issues
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) speaks with Biopharm International.
Advertisement
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) spoke with BioPharm International about drug shortages, manufacturing challenges, and industry issues.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
5




